Biology subjects

Marshall, A. C.

Publications and source records attributed to Marshall, A. C..

5 recordsLinked to original sources

bioRxiv2026

Mapping breast cancer lineage in radiation and immunotherapy using the REMAP mouse

We present REMAP (Recording Evolution in Mammary tumors via Active PyMT), a lineage-tracing mouse model that integrates inducible CRISPR recording with the MMTV-PyMT model of hormone receptor-positive (HR+) breast cancer. Inducible Cas9 drives editing of MARC1 homing guide RNAs (hgRNAs), generating heritable lineage marks, and enables reconstruction of clonal relationships. Using REMAP, we profiled tumor evolution and response to radiation combined with anti-PD1 immunotherapy. Treatment reduced tumor burden locally and systemically, and single-cell RNA sequencing revealed remodeling of the tumor microenvironment (TME). We identified metastatic clones present across primary tumors and distant sites, which exhibited elevated epithelial-mesenchymal transition (EMT) programs as a heritable clonal state. Treatment reduced EMT-associated transcriptional programs and reshaped immune composition, with radiation driving clonal expansion of T cells and reduced repertoire diversity. In contrast, cancer-associated fibroblast clones spanned multiple transcriptional states, indicating substantial stromal plasticity. Together, REMAP enables high-resolution coupling of clonal history and cellular state in vivo, revealing that tumor progression, metastasis, and therapeutic response are governed by heritable lineage programs.

cancer biology↗

bioRxiv2025

Structural and functional characterisation of a reconstructed ancestral strigolactone receptor

Strigolactones are phytohormones that regulate shoot branching and promote root interactions with arbuscular mycorrhizal fungi. In seed plants, strigolactone perception begins with the enzyme-receptor DWARF14 (D14), an /{beta}-hydrolase that is believed to have evolved via gene duplication from the karrikin receptor, KARRIKIN INSENSITIVE2 (KAI2). D14 and KAI2 are highly homologous at the sequence and structural levels, and both proteins bind and cleave similar butenolide compounds. Nevertheless, the two signalling pathways are distinct, as the activity of one receptor cannot compensate for the loss of the other. Here, we apply ancestral sequence reconstruction to generate a D14 protein representative of seed plants to study the evolution of substrate specificity, and to explore desirable traits for protein engineering. We describe the structure, as well as the in vitro and in planta activity of ancestral D14, showing that substrate specificity does not meaningfully differ from that of Arabidopsis thaliana D14. We also demonstrate that ancestral D14 shows higher recombinant yields, greatly increased thermostability, and enhanced catalytic activity relative to D14 from A. thaliana. This work provides insight into the evolution of phytohormone signalling and presents a robust scaffold for the application of D14-type proteins in synthetic biology. SIGNIFICANCE STATEMENTAncestral sequence reconstruction of the strigolactone receptor DWARF14 (D14) reveals that its substrate specificity has remained largely conserved in seed plants. Additionally, the ancestral reconstruction exhibits superior recombinant yields, thermostability, and catalytic activity relative to Arabidopsis thaliana D14, providing both evolutionary insights and promising utility for synthetic biology applications.

plant biology↗

bioRxiv2025

Structural and mechanistic analysis of covalent ligands targeting the RNA-binding protein NONO

RNA-binding proteins (RBPs) play important roles in mRNA transcription, processing, and translation. Chemical tools are lacking for RBPs, which has hindered efforts to perturb and understand RBP function in cells. We recently reported a chloroacetamide compound (R)-SKBG-1 that covalently binds the RBP NONO and stabilizes its interactions with mRNAs, leading to transcriptional remodeling and the suppression of cancer cell growth. Here, we report the crystal structure of an (R)-SKBG-1:NONO complex, which confirms covalent modification of cysteine-145 at a pocket proximal to the RNA-binding interface of the protein. We show that this pocket can also be targeted by a lower reactivity chlorofluoroacetamide analog (R, R)-GL-373, which retains the pharmacological properties of (R)-SKBG-1, including blockade of estrogen receptor expression in breast cancer cells, while displaying much greater proteome-wide selectivity. Our findings thus show that NONO can be targeted by covalent ligands with high specificity to pharmacologically suppress pro-tumorigenic gene products in cancer cells. HighlightsO_LICo-crystal structure reveals how covalent ligands stereoselectively bind NONO C_LIO_LIChlorofluoroacetamides (CFAs) bind NONO with high proteomic selectivity C_LIO_LICFA ligands remodel cancer cell transcriptomes in a NONO-dependent manner C_LIO_LICFA ligands suppress cancer cell growth in a NONO-dependent manner C_LI

biochemistry↗

bioRxiv2022

Different low-complexity regions of SFPQ play distinct roles in the formation of biomolecular condensates

Demixing of proteins and nucleic acids into condensed liquid phases is rapidly emerging as a ubiquitous mechanism governing the organisation of molecules within the cell. Long disordered low complexity regions (LCRs) are a common feature of proteins that form biomolecular condensates. RNA-binding proteins with prion-like composition have been highlighted as drivers of liquid demixing to form condensates such as nucleoli, paraspeckles and stress granules. Splicing factor proline- and glutamine-rich (SFPQ) is an RNA- and DNA-binding protein essential for DNA repair and paraspeckle formation. Here, we show that the shorter C-terminal LCR of SFPQ is the main region responsible for the condensation of SFPQ in vitro and in the cell. In contrast, we find that, unexpectedly, the longer N-terminal prion-like LCR of SFPQ attenuates condensation, suggesting a more regulatory role in preventing aberrant condensate formation in the cell. Our data add nuance to the emerging understanding of biomolecular condensate formation, by providing the first example of a common multifunctional nucleic acid-binding protein with an extensive prion-like region that serves to regulate rather than drive condensate formation. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/518278v2_ufig1.gif" ALT="Figure 1"> View larger version (27K): org.highwire.dtl.DTLVardef@ed464dorg.highwire.dtl.DTLVardef@1a26fdcorg.highwire.dtl.DTLVardef@15debecorg.highwire.dtl.DTLVardef@12bd4ae_HPS_FORMAT_FIGEXP M_FIG C_FIG

molecular biology↗

bioRxiv2022

RNA binding is essential for NONO condensates to modulate pre-mRNA processing in neuroblastoma

High-risk neuroblastoma patients have poor survival rates and require better therapeutic options. High expression of a multifunctional DNA and RNA binding protein, NONO, in neuroblastoma is associated with poor patient outcome, however there is little understanding of the mechanism of NONO-dependent oncogenic gene regulatory activity in neuroblastoma. Here, we used cell imaging, biophysical and molecular analysis to reveal complex NONO-dependent regulation of gene expression, finding that NONO forms RNA- and DNA-tethered phase-separated condensates throughout the nucleus. CLIP analyses show that NONO mainly binds to the 5 end of pre-mRNAs and modulates pre-mRNA processing, dependent on its RNA binding activity. NONO preferentially regulates super enhancer-associated genes, including HAND2 and GATA2. In the absence of functional NONO-RNA condensates, inefficient pre-mRNA processing at these loci leads to decreased expression of HAND2 and GATA2. Thus, future development of agents that target RNA binding activity of NONO may have therapeutic potential in this cancer context.

cell biology↗